Decision Sciences (United States)

Cost-effectiveness of pembrolizumab as neoadjuvant therapy and in combination with standard of care (SOC) as adjuvant therapy for stage III-IVA resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC) in Switzerland

AIMS: KEYNOTE-689 trial results demonstrated that neoadjuvant pembrolizumab followed by adjuvant pembrolizumab plus standard of care (NP/AP + SOC) significantly improved event-free survival (EFS) versus SOC alone in patients with locoregionally advanced head and neck squamous cel...

Pre-trained knowledge transfer with application in multisystem inflammatory syndrome subphenotyping in children

Multisystem inflammatory syndrome in children (MIS-C) is a severe post-acute sequela of SARS-CoV-2 infection in children and presents with highly heterogeneous signs and symptoms. Disentangling the clinical manifestations of MIS-C by characterizing its subphenotypes can help iden...

Federal Supreme Court of Ethiopia Cassation Decision File Number 135316

Decision of the Federal Supreme Court of Ethiopia, Cassation Division, in Cassation File No. 135316. The document is deposited for purposes of public access, legal research, citation, and scholarly discussion. The uploader has not modified the substantive content of the decision.

Federal Supreme Court of Ethiopia Cassation Decision File Number 135316

Decision of the Federal Supreme Court of Ethiopia, Cassation Division, in Cassation File No. 135316. The document is deposited for purposes of public access, legal research, citation, and scholarly discussion. The uploader has not modified the substantive content of the decision.